David Trenk | executive |
Christopher Simon | executive |
Roy Galvin | executive |
James D'Arecca | executive |
Andrew Ranieri | analyst |
Michael Matson | analyst |
Joanne Wuensch | analyst |
Anthony Petrone | analyst |
Andrew Cooper | analyst |
David Turkaly | analyst |
Good day, and welcome to the Haemonetics Third Quarter Fiscal '23 Conference Call and Webcast. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the call over to David Trenk, Manager-Investor Relations.
You may begin.
Good morning, everyone.